Oral Ingestion of Yuzu Seed Oil Suppresses the Development of Atopic Dermatitis-like Skin Lesions in NC/Nga Mice
International Journal of Molecular Sciences · 26.02.2024 · 25 (5) · 2689
DOI: 10.3390/ijms25052689 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.02.2024. Verfasst von Kimito Asano und 4 weiteren Autor:innen. Beteiligte Einrichtung: Kochi-Umajimura Yuzu Health Research Course, Kochi Medical School, Kochi University, Nankoku 783-8505, Japan. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Umajimura Agricultural Cooperative.
Abstract (Originalsprache)
Long-term oral ingestion of unheated yuzu seed oil in humans reduces lipid peroxides in the blood. Moreover, yuzu seed oil contains limonin, which can induce antioxidant and anti-inflammatory effects by activating the transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2). Previously, Nrf2 has been shown to reduce atopic dermatitis (AD). Therefore, we hypothesized that ingesting unheated yuzu seed oil can regulate AD through Nrf2. An AD model was established using NC/Nga mice through repeated local exposure to mite antigens. Unheated and purified yuzu seed oil (100 µL/mice) or water (control, 100 µL/mice) was administered orally once a day using a gastric cannula for rodents for 28 days. On day 28, mice in the unheated yuzu seed oil group exhibited significantly lower clinical skin severity scores and ear thickness than those in the purified yuzu seed oil and water groups. Serum histamine levels remained unaltered among the three AD-induced groups. Serum Dermatophagoides farina body (Dfb)-specific immunoglobulin E (IgE) levels were significantly lower in the unheated yuzu seed oil group. Oral ingestion of yuzu seed oil in NC/Nga AD model mice significantly suppressed dermatitis deterioration and decreased serum IgE levels. Clinical trials (n = 41) have already confirmed that unheated yuzu oil is safe for long-term intake, further suggesting its potential use in improving AD symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kochi-Umajimura Yuzu Health Research Course, Kochi Medical School, Kochi University, Nankoku 783-8505, Japan.
- Umajimura Agricultural Cooperative, Kochi 781-6201, Japan.
ORCID-Profile: Mio Miyamoto, Shunji Mizobuchi
Förderung
- Umajimura Agricultural Cooperative
Zitieren
APA
Asano, K., Watanabe, Y., Miyamoto, M., Toutani, M., & Mizobuchi, S. (2024). Oral Ingestion of Yuzu Seed Oil Suppresses the Development of Atopic Dermatitis-like Skin Lesions in NC/Nga Mice. International Journal of Molecular Sciences, 25(5), 2689. https://doi.org/10.3390/ijms25052689
Vancouver
Asano K, Watanabe Y, Miyamoto M, Toutani M, Mizobuchi S. Oral Ingestion of Yuzu Seed Oil Suppresses the Development of Atopic Dermatitis-like Skin Lesions in NC/Nga Mice. International Journal of Molecular Sciences. 2024;25(5):2689. doi:10.3390/ijms25052689
BibTeX
@article{Asano2024,
author = {Asano, Kimito and Watanabe, Yoshiya and Miyamoto, Mio and Toutani, Mochifumi and Mizobuchi, Shunji},
title = {Oral Ingestion of Yuzu Seed Oil Suppresses the Development of Atopic Dermatitis-like Skin Lesions in NC/Nga Mice},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {5},
pages = {2689},
doi = {10.3390/ijms25052689}
}
EUVIMED